Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Sommerer

Showing results (11-20 of 155) with videos related to

Pageof 16
Sort By:
Clinical Immunology (Orlando, Fla.)|April 29, 2009
Monitoring immunosuppression with measures of NFAT decreases cancer incidenceThomas Giese, Claudia Sommerer, Martin Zeier, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2004
The long-term consequences of living-related or unrelated kidney donationClaudia Sommerer, Christian Morath, Joachim Andrassy, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2008
Pharmacodynamic monitoring of calcineurin inhibitor therapy: is there a clinical benefit?Claudia Sommerer, Thomas Giese, Stefan Meuer, et al.
Nephron. Clinical Practice|September 25, 2007
Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin TClaudia Sommerer, Evangelos Giannitsis, Vedat Schwenger, et al.
Transplantation|May 14, 2010
Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipientsClaudia Sommerer, Martin Zeier, Stefan Meuer, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|November 10, 2010
New concepts to individualize calcineurin inhibitor therapy in renal allograft recipientsClaudia Sommerer, Thomas Giese, Stefan Meuer, et al.
Digestive Diseases (Basel, Switzerland)|May 13, 2010
Approaches towards individualized immune interventionThomas Giese, Claudia Sommerer, Martin Zeier, et al.
Clinical Nephrology|August 1, 2015
Monitoring of calcineurin inhibitors by NFAT-regulated gene expression in de novo renal allograft recipients on cyclosporine AClaudia Sommerer, Martin Zeier, Stefan Meuer, et al.
Therapeutic Drug Monitoring|October 3, 2022
Pharmacodynamic Monitoring of Ciclosporin and Tacrolimus: Insights From Nuclear Factor of Activated T-Cell-Regulated Gene Expression in Healthy VolunteersYoana Aurelia Djaelani, Thomas Giese, Claudia Sommerer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 28, 2002
Hypercalcaemia-induced renal failure-a mysteryDaniel Henriquez-Kries, Claudia Sommerer, Ralf Dikow, et al.
Pageof 16

Showing results (11-20 of 155) with videos related to

Sort By:
Pageof 16
Clinical Immunology (Orlando, Fla.)|April 29, 2009
Monitoring immunosuppression with measures of NFAT decreases cancer incidenceThomas Giese, Claudia Sommerer, Martin Zeier, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2004
The long-term consequences of living-related or unrelated kidney donationClaudia Sommerer, Christian Morath, Joachim Andrassy, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2008
Pharmacodynamic monitoring of calcineurin inhibitor therapy: is there a clinical benefit?Claudia Sommerer, Thomas Giese, Stefan Meuer, et al.
Nephron. Clinical Practice|September 25, 2007
Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin TClaudia Sommerer, Evangelos Giannitsis, Vedat Schwenger, et al.
Transplantation|May 14, 2010
Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipientsClaudia Sommerer, Martin Zeier, Stefan Meuer, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|November 10, 2010
New concepts to individualize calcineurin inhibitor therapy in renal allograft recipientsClaudia Sommerer, Thomas Giese, Stefan Meuer, et al.
Digestive Diseases (Basel, Switzerland)|May 13, 2010
Approaches towards individualized immune interventionThomas Giese, Claudia Sommerer, Martin Zeier, et al.
Clinical Nephrology|August 1, 2015
Monitoring of calcineurin inhibitors by NFAT-regulated gene expression in de novo renal allograft recipients on cyclosporine AClaudia Sommerer, Martin Zeier, Stefan Meuer, et al.
Therapeutic Drug Monitoring|October 3, 2022
Pharmacodynamic Monitoring of Ciclosporin and Tacrolimus: Insights From Nuclear Factor of Activated T-Cell-Regulated Gene Expression in Healthy VolunteersYoana Aurelia Djaelani, Thomas Giese, Claudia Sommerer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 28, 2002
Hypercalcaemia-induced renal failure-a mysteryDaniel Henriquez-Kries, Claudia Sommerer, Ralf Dikow, et al.
Pageof 16